Global Veterinary Infectious Disease Diagnostics Market, By Technology (Immunodiagnostics, Molecular Diagnostics), By Animal-Type (Companion Animals, Food-Producing Animals), By End-User (Reference Laboratories, Veterinary Laboratories, and Clinics, Point of Care / In House Testing, Research Institutes and Universities), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

Published:
May 2021
Report Code:
BWC19327
Available Format:
PDF PDF Icon
Pages:
125

global veterinary infectious disease diagnostics market

Global Veterinary Infectious Disease Diagnostics Market- Industry Trends & Forecast Report 2027

The global veterinary infectious disease diagnostics market was worth USD 1.68 billion in 2020 and is further projected to reach USD 3.07 billion by the year 2027, growing at the CAGR of 9.2% during the forecast period (2020-2027). Rising technological advancement in diagnostic devices, automation, rising companion animal population coupled with the increasing trend of pet insurance is the key factor anticipated to propel the demand of the veterinary infectious disease diagnostics market in the forecast period. Also, rising investment in animal healthcare, increasing incidence of zoonotic diseases, rising disposable income in emerging economies will further drive the global veterinary infectious disease diagnostics.


Source: BlueWeave Consulting

Global Veterinary Infectious Disease Diagnostics Market: Overview

Several contagious diseases affect companion animals. These diseases can prove deadly and can lead to severe complications if not treated promptly. Veterinary infectious disease diagnosis refers to the detection of infectious diseases in animals. These diagnostics are often used to indirectly monitor human health as well. Monitoring and control of zoonotic disease, an infectious disease transmitted from animals to humans, is a crucial part of the veterinary infectious disease diagnostics market.  This is important for food safety, sanitation, and the well-being of both domesticated animals as well as the owner.

Growth Drivers

Growing demand for advanced diagnostic devices 

The rising demand for advanced veterinary infectious disease diagnostic technologies by professionals and practitioners is fueling the growth of the veterinary infectious disease diagnostics market. Advanced diagnostics devices such as nucleic acid diagnostics, biosensors, PCR, and biomarkers are increasingly being used for routine diagnostics. That is why manufacturing companies are increasingly focusing on research and development for launching new and better products which are technologically advanced and effective in diagnostics. These factors are expected to further propel the market during the forecast period.

Increasing Disease Control and Disease Prevention Measures

The growing prevalence of infectious diseases raises the risk of its spread in humans as well. Coronavirus is one of the most pertinent examples of this scenario. Therefore, governments around the world are undertaking a variety of programs to combat the rising prevalence of infectious diseases to prevent a pandemic-like situation in the future. Rising government spending on animal healthcare, along with advanced healthcare facilities, and stringent regulatory and policy reforms are all increasing the demand for effective veterinary infectious disease diagnosis.

Restraints

Increasing Pet Care Costs

Despite growing costs, pet owners are spending enough to properly care for their pets' health. However, with rising technological advancements, coupled with strict regulatory policies, and indirect reforms, the market may experience a setback during the forecast period. All these factors add to the overall cost of pet care and maintenance. With rising inflation, pet owners may try to cut down their overall expenses, which will directly affect the growth of the veterinary infectious disease diagnostics market.

Impact of Covid-19 on the Global Veterinary Infectious Disease Diagnostics Market

The global veterinary infectious disease diagnostics market witnessed tremendous growth since the outbreak of the COVID-19 pandemic. Coronavirus infection is a zoonotic disease that was first discovered in bats. Following the rapid spread of the virus and its global impact, public awareness regarding animal infection and zoonotic diseases increased. Pet owners also began diagnosing their animals regularly to avoid infection. As a result, demand for infectious disease diagnostics increased dramatically in order to avoid the spread of some other virus or pandemic scenario, thereby boosting market development.

Global Veterinary Infectious Disease Diagnostics Market: Technology

Based on technology, the global veterinary infectious disease diagnostics market is segregated into immunodiagnostics and molecular diagnostics. The rising emergence rate of advanced immunoassay formats and diagnostics is likely to contribute a major share to propel the growth of the immunodiagnostics segment in the global veterinary infectious disease diagnostic market during the forecast period. Advantages associated with advanced technologies such as quick, sensitive, and accurate diagnosis, high rate of efficacy, and accurate result validation, coupled with the rising incidence of infectious diseases are anticipated to support the growth of the global veterinary infectious disease diagnostics market in upcoming years.

Global Veterinary Infectious Disease Diagnostics Market: Animal Type

Based on animal type, the global veterinary infectious disease diagnostics market is segmented into companion animals and food-producing animals. The companion animals segment holds the largest market share. The highly infectious nature of viral diseases is a significant factor driving the demand for viral infection diagnosis in companion animals. Additionally, the rising number of pet owners due to the humanization of animals as well as the need for companionship contribute to the growth of this segment. Increasing bacterial infection and worm infestation incidences are also likely to contribute to the growing companion animal segment in the global veterinary infectious disease diagnostic market during the forecast period.

Global Veterinary Infectious Disease Diagnostics Market: End-User

Based on the end-user, the global veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes & universities. The reference laboratories accounted for the largest market share. Reference laboratories are private facilities that perform diagnosis and offer a wide variety of tests. These laboratories handle high volumes of routine testing due to which it has high demand in the veterinary infectious disease diagnostics market. Hospitals and clinics are also contributing to market growth because they are the first choice of animal owners for first-point care.

Global Veterinary Infectious Disease Diagnostics Market: Regional Insights

Geographically, the global veterinary infectious disease diagnostics market is segmented into North America, Europe, Asia-Pacific (APAC), Latin America, Middle-East & Africa. Among these regions, North America is expected to hold the largest market share followed by Europe due to factors such as favorable healthcare infrastructure and the availability of numerous market players in these regions. Furthermore, the availability of diagnostic devices, as well as increased pet ownership and growing healthcare spending, are driving market growth in North America. Additionally, increasing companion animal ownership, combined with favorable animal welfare policies, is expected to drive the North American market during the forecast period.


Competitive Landscape

The leading market players of the global veterinary infectious disease diagnostics market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players.

The market players are constantly adopting growth strategies such as partnerships, mergers & acquisitions, etc., to expand their consumer base. They are also focusing on the launch of innovative and technologically advanced products to stay ahead of the curve.

Recent Developments

l  In May 2021, The American Academy of Dermatology (AAD) reported a USD 7 million investment to extend the company's point-of-care target. This investment is geared toward One Health's agenda of promoting animal, human, and environmental health.

l  In July 2020, LexaGene, a US-based molecular diagnostics company, announced the launch of a new genetic analyzer called ‘MiQLab. This technology can be used for performing real-time veterinary diagnostics testing at the point of care.


Scope of the Report

Attributes

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa

Product Service/Segmentation

By Technology, By Animal-Type, By End-User, By Region

Key Players

Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, QIAGEN N.V. (A Part of Indical Bioscience), Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Zoetis, Inc., Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players.

 

By Technology

Ø  Immunodiagnostics

Lateral Flow Assays

ELISA Tests

Other Immunodiagnostic Technologies

Ø  Molecular Diagnostics

Polymerase Chain Reaction (PCR) Tests

Microarrays

Other Molecular Diagnostic Tests

By Animal Type

Ø  Companion Animals

Ø  Food-Producing Animals

By End-User

Ø  Reference Laboratories

Ø  Veterinary Laboratories and Clinics

Ø  Point of Care / In House Testing

Ø  Research Institutes and Universities

By Region

Ø  North America

Ø  Europe

Ø  Asia-Pacific (APAC)

Ø  Latin America (LATAM)

Ø  Middle-East & Africa (MEA)

FAQs:

1. What is the current size of the global veterinary infectious disease diagnostics market?

Answer: The global veterinary infectious disease diagnostics market reached USD 1.68 billion in 2020.

2. What are the major factors driving the growth of the global veterinary infectious disease diagnostics market?

Answer: The major factors driving the growth of the global veterinary infectious disease diagnostics market are the growing demand for advanced diagnostic devices and increasing disease control and disease prevention measures. 

3. Who are the key players in the global veterinary infectious disease diagnostics market?

Answer: The key players in the global veterinary infectious disease diagnostics market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, QIAGEN N.V. (A Part of Indical Bioscience), Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Zoetis, Inc., Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players.

4. Which animal-type segment accounted for the largest share in the global veterinary infectious disease diagnostics market?

Answer: The companion animals segment accounted for the largest share in the global veterinary infectious disease diagnostics market.

5. Which region is at the highest growth rate in the global veterinary infectious disease diagnostics market?

Answer: North America has the largest share in the global veterinary infectious disease diagnostics market.

COVID-19

We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at

Contact Now

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.